ÂÜÀòÂÒÂ×

Jeroen Tas is a prominent figure in the healthcare sector, currently serving as a member of the Board for DON T1 Diabetes Research Netherlands and as a Scientific Advisory Board Member for Johnson & Johnson MedTech. Tas holds the position of Chairman of the Healthcare Innovation Committee at GBL (Groupe Bruxelles Lambert) and has been a member of the Supervisory Board for A3P Biomedical, Quantiphi, and Zylorion Health. Additionally, Tas is an advisor at Multiples Alternate Asset Management and the founder of Fast&Slow BV, which focuses on strategy advisory and angel investments. Tas previously served on the Board of Directors for Gaia-X Association for Data and Cloud. Tas possesses a Master's Degree in Business Administration and Computer Science from Vrije Universiteit Amsterdam, alongside a strong academic foundation from Stedelijk Gymnasium Leiden.